Navigation Links
Intarcia Therapeutics, Inc. Announces Completion of Enrollment of ITCA 650 Phase 1b Study for the Treatment of Type 2 Diabetes
Date:4/24/2009

nce the therapeutic effects of exenatide by ensuring patient compliance and providing more consistent, round-the-clock therapeutic drug levels; and to reduce side effects, including nausea, associated with high peak levels of exenatide exposure observed with injection administration. Unlike other extended delivery technologies such as polymers or albumin fusion, DUROS delivery allows for steady state drug delivery upon insertion and near immediate withdrawal of therapy to manage side effects, if required.

"We are very pleased with the rapid progress the Company has made with ITCA 650," said Alice Leung, President & CEO of Intarcia. "Our team has demonstrated the great potential for DUROS delivered therapies in advancing this important treatment candidate for type 2 diabetes patients from an idea to clinical stage development in 18 months."

ITCA 650 is the second DUROS delivery program Intarcia has moved into clinical development. In December 2008, Intarcia also completed enrollment of a phase 1b study for ITCA 638, which involves DUROS delivery of omega interferon for the treatment of chronic hepatitis C infection. "Many patients with type 2 diabetes are forced to manage dosing schedules and side effects of multiple drug therapies simultaneously to adequately control their disease," commented Ken Luskey, M.D., VP, Clinical Research at Intarcia. "We believe ITCA 650 will deliver improved glycemic control and provide a better tolerated, more convenient treatment option."

About Intarcia

Intarcia Therapeutics, Inc. is a biopharmaceutical company developing therapies to ensure enhanced treatment outcome by optimizing patient adherence and improving the convenience and tolerability of drug therapies. Intarcia's drug development expertise and competitive edge are demonstrated by its abilities to stabilize proteins and peptides at above body temperature and to deliver them in a constant and consistent manner via
'/>"/>

SOURCE Intarcia Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
2. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
3. Cell Therapeutics, Inc. (CTI) Supports Panel Discussion on Women and Lung Cancer on Capitol Hill
4. Velcura Therapeutics, Inc. Reports Positive Pre-IND Meeting With FDA and Plans Early Clinical Trials for New Drug to Treat Multiple Myeloma Bone Disease
5. NIST Awards $2 Million to Velcura Therapeutics, Inc. for Innovative Technology R&D - Dual-Action Therapies for Bone Disease
6. Ocera Therapeutics, Inc. Completes Enrollment in FHAST1, a Pivotal Phase 3 Clinical Trial in Fistulizing Crohns Disease
7. William R. Ringo Joins Hyperion Therapeutics, Inc. Board of Directors as Chairman
8. Cell Therapeutics, Inc. (CTI) Submits European Marketing Authorization Application for XYOTAX(TM)
9. Dynamis Therapeutics, Inc. Discovers RAGE Inhibitor
10. Cell Therapeutics, Inc. (CTI) Announces Enrollment Complete in Phase III EXTEND (PIX301) Clinical Trial of Pixantrone in Patients With Second or Greater Relapse of Diffuse Large B Cell NHL
11. European Regulatory Agency Accepts Cell Therapeutics, Inc.s Marketing Authorization Application for XYOTAX(TM) for Lung Cancer for Review
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... Feb. 27, 2015  Finesse expands office in ... announced the expansion of its operations in ... mid-March and access for customers is expected shortly afterward. ... located adjacent to the current office, the new premises ... team and allow Finesse to bring on more service ...
(Date:2/26/2015)... 2015  Today the National Safety Council ... physical side effects of pain medications , ... Vicodin and Oxycontin, are safer options than over-the-counter pain ... painkillers than on heroin and cocaine combined," said ... "Yet, these medications are marketed as the Cadillac option ...
(Date:2/26/2015)... Legislation passed today by the House Ways and Means ... prescriptions in Medicare Part D from crossing the pharmacy ... (PIMA) of 2014 , introduced by Ways and Means ... Ranking Member Jim McDermott (D-WA), recognizes the need to ... right policies, said the Pharmaceutical Care Management Association (PCMA). ...
Breaking Medicine Technology:New Finesse Office in United Kingdom 2National Safety Council: Opioid prescription painkillers have hidden, deadly side effects 2PCMA Statement on the 'Protecting the Integrity of Medicare Act' 2
... - NEOPHARM, Inc.,(Nasdaq: NEOL) today reported findings ... metastatic colorectal cancer patients with its,drug product ... While the interim analysis of data following ... patients demonstrated,disease stabilization, the study did not ...
... OTCBB: CHKT, VANCOUVER, April 02, 2007 /PRNewswire-FirstCall/ ... biotechnology company,developing chemokine-based therapies to treat cancer, ... the,University of Texas M. D. Anderson Cancer ... metastasis with a CXCR4,antagonist in a mouse ...
Cached Medicine Technology:NeoPharm Provides Update on LE-SN38 Program 2M. D. Anderson Cancer Center Researchers to Present CTCE-9908 Data,at the AACR Annual Meeting 2M. D. Anderson Cancer Center Researchers to Present CTCE-9908 Data,at the AACR Annual Meeting 3M. D. Anderson Cancer Center Researchers to Present CTCE-9908 Data,at the AACR Annual Meeting 4
(Date:2/28/2015)... The noted Friedman Dental Group of South Florida ... their website. The new version of the site is ... section about their team members. Potential and current patients ... each Friedman Dental Group team member including new staff. ... provide our patients with the opportunity to get to ...
(Date:2/28/2015)... Developers of FCPX plugins and theme templates ... Final Cut Pro X entitled FCPX Overlay Chromatic Grunge 6K ... total control over 6k lens dirt overlays inside Final Cut ... “FCPX Overlay Chromatic was professionally designed to add level of ... Overlay Chromatic Grunge 6K is a resourceful tool from Pixel ...
(Date:2/28/2015)... 2015 “ Powermod ” was featured on ... a look at the latest and coolest technology products and ... NewsWatch and a technology expert, conducted the review and shared ... solutions. , Getting stuck with a low battery and no ... that people face on a daily basis. Even when a ...
(Date:2/28/2015)... Memphis, TN: MedixSafe has retracted a previous ... security reader named Guardian 2. The correct product ... biometric scanner that significantly increases the complexity of ... biometric scanner provides fast and easy access for ... narcotics lockers with Vanguard technology tracks inventory ...
(Date:2/28/2015)... My Shiney Hiney® LLC., the renowned brand ... Las Vegas, Nevada for the annual ASD Market Week tradeshow. ... leading consumer-goods tradeshows and My Shiney Hiney will be one ... Shiney Hiney can be found at booth number C1663. , ... at-home personal hygiene brush and cleansing system exclusively created to ...
Breaking Medicine News(10 mins):Health News:Friedman Dental Group Announces Their Updated Website 2Health News:Pixel Film Studios released a new overlay plugin entitled FCPX Overlay Chromatic Grunge 6K exclusively for Final Cut Pro X users 2Health News:Solutions to Keep Phones Charged were Featured on NewsWatch Television on January 29, 2015 2Health News:New Name Announced For Newest MedixSafe Readers – MedixSafe Vanguard 2Health News:My Shiney Hiney® to Participate in ASD Market Week 2015 2
... McGovern Institute for Brain Research will head an ambitious ... dyslexia, supported by a $8.5M grant from the Ellison ... Gabrieli, are prominent experts in neuroimaging and human brain ... that first appear in early childhood. Autism impairs social ...
... (Pink Sheets: HRAL)-,HearAtLast Holdings, Inc. is proud to announce ... WMT ) to open its 17th hearing-aid,clinic to ... 450,Stevenson Road South, Oshawa, Ontario. The clinic officially opened ... the HearAtLast chain. The,Company currently owns and operates 16 ...
... Prefer to Store,Their Supplements in the Kitchen Cabinet, ... minerals, and other supplements? Is it the kitchen cabinet, ... bathroom cabinet,possibly next to the toothpaste and dental floss? ... and stash of granola bars and M&Ms,for those rainy ...
... running for office in 2008 should commit to an agenda ... that is second to none the American College of Physicians ... of the Nations Health Care. In its report, ACP offers ... support a series of recommendations. , The recommendations result from ...
... Imaging to Deliver ... Exceptional Accuracy, CHARLESTON, S.C., ... Medical University of South Carolina,s Hollings,Cancer Center have partnered to bring ... The TomoTherapy Hi-Art Treatment System is one of two available ...
... Jan. 31 Horace Mann,Educators Corporation (NYSE: HMN ... February 6, 2008 after the market closes. The,earnings press ... section of the Company,s website at http://www.horacemann.com .,Management ... results on,Thursday, February 7, 2008 at 10:00 a.m. ET., ...
Cached Medicine News:Health News:MIT's McGovern Institute researchers awarded $8.5M to study brain basis of autism and dyslexia 2Health News:HearAtLast Expands Chain to 17 Locations, Opening New Clinic in Oshawa, Ontario Wal-Mart Supercenter # 1056 2Health News:HearAtLast Expands Chain to 17 Locations, Opening New Clinic in Oshawa, Ontario Wal-Mart Supercenter # 1056 3Health News:HearAtLast Expands Chain to 17 Locations, Opening New Clinic in Oshawa, Ontario Wal-Mart Supercenter # 1056 4Health News:Finding the Right Home for Your Vitamins and Other Supplements 2Health News:Finding the Right Home for Your Vitamins and Other Supplements 3Health News:Achieving a US health care system 'second to none' 2Health News:Achieving a US health care system 'second to none' 3Health News:Achieving a US health care system 'second to none' 4Health News:MUSC's Hollings Cancer Center, Ralph H. Johnson VA Medical Center Partner on New TomoTherapy Treatment for Cancer Patients 2Health News:Horace Mann Announces Fourth Quarter Earnings Release and Conference Call 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: